{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T07:26:40Z","timestamp":1780730800975,"version":"3.54.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12884-016-1177-4","type":"journal-article","created":{"date-parts":[[2017,1,17]],"date-time":"2017-01-17T23:29:23Z","timestamp":1484695763000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Design and rationale of a large, international, prospective cohort study to evaluate the occurrence of malformations and perinatal\/neonatal death using insulin detemir in pregnant women with diabetes in comparison with other long-acting insulins"],"prefix":"10.1186","volume":"17","author":[{"given":"Elisabeth R.","family":"Mathiesen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia I. I.","family":"Kring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Damm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,18]]},"reference":[{"key":"1177_CR1","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.2337\/dc09-0656","volume":"32","author":"M Persson","year":"2009","unstructured":"Persson M, Norman M, Hanson U. Obstetric and perinatal outcomes in type 1 diabetic pregnancies: A large, population-based study. Diabetes Care. 2009;32:2005\u20139.","journal-title":"Diabetes Care"},{"key":"1177_CR2","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3109\/00016349.2010.518594","volume":"89","author":"I Eidem","year":"2010","unstructured":"Eidem I, Stene LC, Henriksen T, Hanssen KF, Vangen S, Vollset SE, Joner G. Congenital anomalies in newborns of women with type 1 diabetes: nationwide population-based study in Norway, 1999\u20132004. Acta Obstet Gynecol Scand. 2010;89:1403\u201311.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"1177_CR3","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1007\/s00125-011-2281-7","volume":"54","author":"I Eidem","year":"2011","unstructured":"Eidem I, Vangen S, Hanssen KF, Vollset SE, Henriksen T, Joner G, Stene LC. Perinatal and infant mortality in term and preterm births among women with type 1 diabetes. Diabetologia. 2011;54:2771\u20138.","journal-title":"Diabetologia"},{"key":"1177_CR4","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.2337\/diacare.27.12.2819","volume":"27","author":"DM Jensen","year":"2004","unstructured":"Jensen DM, Damm P, Moelsted-Pedersen L, Ovesen P, Westergaard JG, Moeller M, Beck-Nielsen H. Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study. Diabetes Care. 2004;27:2819\u201323.","journal-title":"Diabetes Care"},{"key":"1177_CR5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s001250050010","volume":"43","author":"L Suhonen","year":"2000","unstructured":"Suhonen L, Hiilesmaa V, Teramo K. Glycaemic control during early pregnancy and fetal malformations in women with type I diabetes mellitus. Diabetologia. 2000;43:79\u201382.","journal-title":"Diabetologia"},{"key":"1177_CR6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/dmrr.1213","volume":"27","author":"ER Mathiesen","year":"2011","unstructured":"Mathiesen ER, Damm P, Jovanovic L, McCance DR, Thyregod C, Jensen AB, Hod M. Basal insulin analogues in diabetic pregnancy: a literature review and baseline results of a randomised, controlled trial in type 1 diabetes. Diabetes Metab Res Rev. 2011;27:543\u201351.","journal-title":"Diabetes Metab Res Rev"},{"key":"1177_CR7","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3109\/14767058.2012.743523","volume":"26","author":"NF Callesen","year":"2013","unstructured":"Callesen NF, Damm J, Mathiesen JM, Ringholm L, Damm P, Mathiesen ER. Treatment with the long-acting insulin analogues detemir or glargine during pregnancy in women with type 1 diabetes: comparison of glycaemic control and pregnancy outcome. J Matern Fetal Neonatal Med. 2013;26:588\u201392.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"1177_CR8","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.2337\/dc11-2264","volume":"35","author":"ER Mathiesen","year":"2012","unstructured":"Mathiesen ER, Hod M, Ivanisevic M, Duran Garcia S, Br\u00f8ndsted L, Jovanovic L, Damm P, McCance DR, Detemir in Pregnancy Study Group. Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes. Diabetes Care. 2012;35:2012\u20137.","journal-title":"Diabetes Care"},{"key":"1177_CR9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/14767058.2013.799650","volume":"27","author":"M Hod","year":"2014","unstructured":"Hod M, Mathiesen ER, Jovanovi\u010d L, McCance DR, Ivanisevic M, Dur\u00e1n-Garcia S, Br\u00f8ndsted L, Nazeri A, Damm P. A randomized trial comparing perinatal outcomes using insulin detemir or neutral protamine Hagedorn in type 1 diabetes. J Matern Fetal Neonatal Med. 2014;27:7\u201313.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"1177_CR10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/bmj.38856.692986.AE","volume":"333","author":"MC Macintosh","year":"2006","unstructured":"Macintosh MC, Fleming KM, Bailey JA, Doyle P, Modder J, Acolet D, Golightly S, Miller A. Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ. 2006;333:177.","journal-title":"BMJ"},{"key":"1177_CR11","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1136\/bmj.38043.583160.EE","volume":"328","author":"IM Evers","year":"2004","unstructured":"Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ. 2004;328:915.","journal-title":"BMJ"},{"key":"1177_CR12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-2006-957073","volume":"210","author":"HH G\u00fcnter","year":"2006","unstructured":"G\u00fcnter HH, Scharf A, Hertel H, Hillemanns P, Wenzlaff P, Maul H. Perinatal morbidity in pregnancies of women with preconceptional and gestational diabetes mellitus in comparison with pregnancies of non-diabetic women. Results of the perinatal registry of Lower Saxony, Germany]. [Article in German]. Z Geburtshilfe Neonatol. 2006;210:200\u20137.","journal-title":"Z Geburtshilfe Neonatol"},{"key":"1177_CR13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bpobgyn.2010.11.001","volume":"25","author":"ER Mathiesen","year":"2011","unstructured":"Mathiesen ER, Ringholm L, Damm P. Stillbirth in diabetic pregnancies. Best Pract Res Clin Obstet Gynaecol. 2011;25:105\u201311.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"1177_CR14","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.diabres.2008.04.007","volume":"81","author":"M Monami","year":"2008","unstructured":"Monami M, Marchionni N, Mannucci E. Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysis. Diabetes Res Clin Pract. 2008;81:184\u20139.","journal-title":"Diabetes Res Clin Pract"},{"key":"1177_CR15","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1463-1326.2008.00976.x","volume":"11","author":"M Monami","year":"2009","unstructured":"Monami M, Marchionni N, Mannucci E. Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta-analysis. Diabetes Obes Metab. 2009;11:372\u20138.","journal-title":"Diabetes Obes Metab"},{"key":"1177_CR16","unstructured":"Novo Nordisk: Levemir Summary of Product Characteristics. Available at: www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000528\/WC500036662.pdf . Accessed July 2014."},{"key":"1177_CR17","unstructured":"Sanofi-Aventis: Lantus Summary of Product Characteristics. Available at: www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000284\/WC500036082.pdf . Accessed July 2014."},{"key":"1177_CR18","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1464-5491.2012.03604.x","volume":"29","author":"L Ringholm","year":"2012","unstructured":"Ringholm L, Pedersen-Bjergaard U, Thorsteinsson B, Damm P, Mathiesen ER. Hypoglycaemia during pregnancy in women with type 1 diabetes. Diabetic Med. 2012;29:558\u201366.","journal-title":"Diabetic Med"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-016-1177-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T04:29:35Z","timestamp":1498364975000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-016-1177-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,18]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1177"],"URL":"https:\/\/doi.org\/10.1186\/s12884-016-1177-4","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,18]]},"article-number":"38"}}